This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IBM Touts 'Watson' Supercomputer for the Health-Care Industry

NEW YORK ( TheStreet) -- IBM (IBM - Get Report) achieved a feat two years ago when the tech giant's Watson supercomputer beat two human champions in the Jeopardy TV quiz. Now keen to bring high-end computing to the corporate masses, IBM unveiled the first commercial Watson-based technologies on Friday.

The company picked the lucrative health-care sector as the launch pad for this effort, teaming up with health-insurance firm WellPoint (WLP) and New York's prestigious Memorial Sloan Kettering Cancer Care Center.

"We chose health care as a starting point," said Manoj Saxena, general manager of IBM's Watson Solutions, during the New York launch event. "We believe it's ready for transformation in the context of big data and analytics -- we believe that Watson will change the way that medicine is taught, practiced and paid for."

IBM has been working closely with WellPoint and Memorial Sloan Kettering to "teach" Watson how to process and analyze clinical data, specifically around cancer care. The supercomputer has already ingested more than 600,000 pieces of medical evidence, according to Big Blue, as well as 2 million pages of text from clinical oncology trials.

WellPoint has used Watson to build technology for streamlining the review processes between a patient's physicians and their health plan, which it says will speed up approvals.

"By the end of the year, 50% of our nurses will be using Watson," WellPoint Executive Vice President Lori Leer said during a presentation at IBM's New York headquarters.

The Indianapolis-based firm also worked with IBM and Memorial Sloan-Kettering on Interactive Care Insights for Oncology, a cloud-based service that can help identify individual treatment options for cancer patients, starting with lung cancer.

IBM's Saxena noted that health care is a "$2 trillion industry," highlighting the market opportunity for IBM. The Armonk, New York-based firm, which recently posted robust fourth-quarter results, expects to generate $16 billion in analytics revenue by 2015.

Big Blue also discussed the broader potential for Watson on Friday. Saxena, for example, cited six "instances" of Watson being deployed in the past 12 months.

"We are using Watson beyond health care in financial services, and we have just signed up some telco customers -- you will see more of these announcements later in the year," he told TheStreet. "Watson is really well-suited for information-intensive industries such as insurance, health care, telecom and banking."

IBM shares rose 0.9% to $201.57 in Friday trading.

-- Written by James Rogers in New York

>To submit a news tip, send an email to:

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
IBM $149.02 0.16%
WLP $136.01 1.43%
AAPL $109.79 -1.40%
FB $91.60 -1.30%
GOOG $636.42 -1.40%


Chart of I:DJI
DOW 16,778.37 -11.82 -0.07%
S&P 500 1,976.44 -3.48 -0.18%
NASDAQ 4,728.8240 -19.5370 -0.41%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs